The Malaysian healthcare and pharmaceuticals sector has been growing strongly as a result of factors including one of the highest population growth rates in the ASEAN region, increasing affluence, and growing access to healthcare funding. In healthcare services, Malaysia operates a hybrid publicprivate system where inadequate healthcare provision in the public system has led to the proliferation of private hospitals, some of which provide international-quality tertiary care. As a result, Malaysia has developed a reputation as a medical tourism destination. Malaysia is a net exporter of medical devices, particularly in the consumables product category. Malaysia is a net importer of pharmaceuticals and is almost wholly reliant on imports to meet its demand for patented drugs.

01 EXECUTIVE SUMMARY

Sector in Numbers

Sector Overview

Sector Snapshot

Sector Outlook

Subsector Outlook

Driving Forces

Restraining Forces

02 SECTOR IN FOCUS

Main Economic Indicators

Main Sector Indicators

Health Profile

Healthcare Expenditure

GST

Exchange Rates

Consumer Prices

Industrial Production

FDI

Employment

Global Positioning – Healthcare

03 COMPETITIVE LANDSCAPE

Highlights

Top Companies in Healthcare Sector

Top Companies in Pharmaceuticals Sector

Top M&A Deals

M&A Activity, 2015-2016

04 COMPANIES IN FOCUS

KPJ Healthcare Bhd

IHH Healthcare Bhd

Pharmaniaga Bhd

CCM Duopharma Biotech Bhd

Apex Healthcare Bhd

05 REGULATORY ENVIRONMENT

Government Policy

06 HEALTHCARE SERVICES

Highlights

Main Events

Healthcare Services Supply

Healthcare Demand

Medical Tourism

07 MEDICAL DEVICES

Highlights

External Trade in Medical Devices

Consumables

Diagnostic Imaging

Patient Aids

08 PHARMACEUTICALS

Highlights

Focus Point – Number of Pharmacies by State

External Trade in Pharmaceuticals

Prescription Drugs

OTC Drugs

Health Supplements

Traditional and Complementary Medicine

09 RETAIL CHANNELS

Pharmaceuticals Distribution

Pharmaceuticals Workforce